Marios Spanakis, PhD
Marios Spanakis, PhD
Collaborating Researcher at FORTH-ICS, Computational BioMedicine Lab
Verified email at ics.forth.gr - Homepage
TitleCited byYear
Controlled release of 5-fluorouracil from microporous zeolites
M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014
442014
Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal …
V Kimiskidis, M Spanakis, I Niopas, D Kazis, C Gabrieli, FI Kanaze, ...
Journal of pharmaceutical and biomedical analysis 43 (2), 763-768, 2007
382007
Potential drug–drug interactions in prescriptions dispensed in community pharmacies in Greece
A Chatsisvili, I Sapounidis, G Pavlidou, E Zoumpouridou, VA Karakousis, ...
Pharmacy world & science 32 (2), 187-193, 2010
362010
Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic …
M Spanakis, S Kasmas, I Niopas
Biomedical Chromatography 23 (2), 124-131, 2009
362009
A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological …
M Spanakis, IS Vizirianakis, I Mironidou-Tzouvelekib, Maria, Niopas
Biomed. Chromatogr 23, 1131-1137, 2009
192009
Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits
M Spanakis, IS Vizirianakis, G Batzias, I Niopas
Pharmacology 91 (1-2), 112-116, 2013
152013
Determination of atenolol in human plasma by HPLC with fluorescence detection: validation and application in a pharmacokinetic study
M Spanakis, I Niopas
Journal of chromatographic science 51 (2), 128-132, 2012
142012
Bioactive Self‐Assembling Lipid‐Like Peptides as Permeation Enhancers for Oral Drug Delivery
C Karavasili, M Spanakis, D Papagiannopoulou, IS Vizirianakis, ...
Journal of pharmaceutical sciences 104 (7), 2304-2311, 2015
132015
Designing a digital patient avatar in the context of the MyHealthAvatar project initiative
E Maniadi, H Kondylakis, EG Spanakis, M Spanakis, M Tsiknakis, ...
Bioinformatics and Bioengineering (BIBE), 2013 IEEE 13th International …, 2013
92013
GC–MS Simultaneous determination of enalapril and enalaprilat in human plasma: Application to a clinical pharmacokinetic study
M Spanakis, I Niopas
Chromatographia 72 (9-10), 957-962, 2010
82010
Clinical and pharmacogenomic assessment of herb-drug interactions to improve drug delivery and pharmacovigilance
SI Vizirianakis, M Spanakis, A Termentzi, I Niopas, E Kokkalou
Plants in traditional and modern medicine: chemistry and activity, 978-81, 2010
72010
Secure access to patient's health records using SpeechXRays a mutli-channel biometrics platform for user authentication
EG Spanakis, M Spanakis, A Karantanas, K Marias
Engineering in Medicine and Biology Society (EMBC), 2016 IEEE 38th Annual …, 2016
62016
Enabling personalized cancer medicine decisions: the challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics
IS Vizirianakis, GA Mystridis, K Avgoustakis, DG Fatouros, M Spanakis
Oncology reports 35 (4), 1891-1904, 2016
62016
Exploitation of patient avatars towards stratified medicine through the development of in silico clinical trials approaches
M Spanakis, E Papadaki, D Kafetzopoulos, A Karantanas, TG Maris, ...
13th IEEE International Conference on BioInformatics and BioEngineering, 1-4, 2013
42013
In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform
M Spanakis, K Marias
In silico pharmacology 2 (1), 2, 2014
32014
GC-MS Analysis of Volatile Constituents of Cornus mas Fruits and Pulp
C Bakirtzi, P Tsatalas, M Spanakis, E Kokkalou
Journal of Essential Oil Bearing Plants 16 (2), 183-200, 2013
32013
PDCA: An eHealth service for the management of drug interactions with complementary and alternative medicines
M Spanakis, S Sfakianakis, EG Spanakis, G Kallergis, V Sakkalis
Biomedical & Health Informatics (BHI), 2018 IEEE EMBS International …, 2018
22018
Assessment of DCE–MRI parameters for brain tumors through implementation of physiologically–based pharmacokinetic model approaches for Gd-DOTA
M Spanakis, E Kontopodis, S Van Cauter, V Sakkalis, K Marias
Journal of pharmacokinetics and pharmacodynamics 43 (5), 529-547, 2016
22016
Addressing drug-drug and drug-food interactions through personalized empowerment services for healthcare
M Spanakis, EG Spanakis, H Kondylakis, S Sfakianakis, I Genitsaridi, ...
Engineering in Medicine and Biology Society (EMBC), 2016 IEEE 38th Annual …, 2016
22016
In vitro inhibition of CYP3A4 and CYP2D6 activity by the horse chestnut constituents’ aescin and aesculetin
M Spanakis, IS Vizirianakis, M Mironidou-Tzouveleki, I Niopas
Front. Pharmacol. Conference Abstract: 8th Southeast European Congress on …, 2010
22010
The system can't perform the operation now. Try again later.
Articles 1–20